News

Bangkok, July 2018 – After successfully completing a series of clinical trials across Southeast Asia, atypical cell detection specialist X-ZELL is now making the company’s patented Cryoimmunostaining™ technology available to research organisations around the globe....

Brisbane, July 2018 – X-ZELL CEO, Dr Sebastian Bhakdi, will use the upcoming Asia-Pacific Prostate Cancer Conference (APCC) in Brisbane next month as a platform to reveal “exciting new insights” into early prostate cancer detection. According to Dr Bhakdi, his...

Singapore, June 2018 – The Department of Urology at Singapore’s National University Hospital and X-ZELL have signed a Letter of Intent (LOI) to jointly conduct a prospective, blinded study evaluating the utility of X-ZELL Prostate™ for early prostate cancer detection....

Basel, June 2018 – Dr Sebastian Bhakdi, CEO of cancer detection start-up X-ZELL Inc., has outlined a ground-breaking new microscopy technique in the June edition of Methods & Protocols. In a bid to make the benefits of X-ZELL's new Cryoimmunostaining™ technology...

Singapore, March 2018 – X-ZELL is proud to confirm a special presentation by company CEO, Dr Sebastian Bhakdi, at the 2018 HealthInvestor Asia Summit in Singapore on 15 May 2018. The TED-style presentation will give attendees a world-exclusive first look behind the...

Bangkok, September 2017 – Dr Sebastian Bhakdi, founder and CEO of Bangkok-based medical technology company X-ZELL, has been confirmed as the keynote speaker for the 2017 Bio Pitch & Partner Conference, which will be held as part of the Thailand LAB 2017...

Bangkok, August 2017 – X-ZELL, a pioneering company in the field of next-generation cytology, has announced the appointment of Sebastian Grote as Head of Marketing & Communications. Grote most recently served as Managing Editor at Prime Creative Media, a...